These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11743396)

  • 1. From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes.
    Britto JA; Evans RD; Hayward RD; Jones BM
    Plast Reconstr Surg; 2001 Dec; 108(7):2026-39; discussion 2040-6. PubMed ID: 11743396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
    Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
    J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward pathogenesis of Apert cleft palate: FGF, FGFR, and TGF beta genes are differentially expressed in sequential stages of human palatal shelf fusion.
    Britto JA; Evans RD; Hayward RD; Jones BM
    Cleft Palate Craniofac J; 2002 May; 39(3):332-40. PubMed ID: 12019011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fgfr mRNA isoforms in craniofacial bone development.
    Rice DP; Rice R; Thesleff I
    Bone; 2003 Jul; 33(1):14-27. PubMed ID: 12919696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification.
    Delezoide AL; Benoist-Lasselin C; Legeai-Mallet L; Le Merrer M; Munnich A; Vekemans M; Bonaventure J
    Mech Dev; 1998 Sep; 77(1):19-30. PubMed ID: 9784595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of FGF and TWIST in calvarial bone and suture development.
    Rice DP; Aberg T; Chan Y; Tang Z; Kettunen PJ; Pakarinen L; Maxson RE; Thesleff I
    Development; 2000 May; 127(9):1845-55. PubMed ID: 10751173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault.
    Iseki S; Wilkie AO; Morriss-Kay GM
    Development; 1999 Dec; 126(24):5611-20. PubMed ID: 10572038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF signaling in craniofacial biological control and pathological craniofacial development.
    Hatch NE
    Crit Rev Eukaryot Gene Expr; 2010; 20(4):295-311. PubMed ID: 21395503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
    Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
    Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of fibroblast growth factor receptors in human digital development suggests common pathogenesis in complex acrosyndactyly and craniosynostosis.
    Britto JA; Chan JC; Evans RD; Hayward RD; Jones BM
    Plast Reconstr Surg; 2001 May; 107(6):1331-8; discussion 1339-45. PubMed ID: 11335797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE
    Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics of craniofacial development].
    van Adrichem LN; Hoogeboom AJ; Wolvius EB
    Ned Tijdschr Tandheelkd; 2008 Feb; 115(2):61-8. PubMed ID: 18326400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic features of syndromic craniosynostoses correlate with differential expression of fibroblast growth factor receptors 1 and 2 during human craniofacial development.
    Chan CT; Thorogood P
    Pediatr Res; 1999 Jan; 45(1):46-53. PubMed ID: 9890607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early mandibular morphological differences in patients with FGFR2 and FGFR3-related syndromic craniosynostoses: A 3D comparative study.
    Morice A; Cornette R; Giudice A; Collet C; Paternoster G; Arnaud É; Galliani E; Picard A; Legeai-Mallet L; Khonsari RH
    Bone; 2020 Dec; 141():115600. PubMed ID: 32822871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A; Bellosta P; Sahni M; Basilico C
    J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2.
    Iseki S; Wilkie AO; Heath JK; Ishimaru T; Eto K; Morriss-Kay GM
    Development; 1997 Sep; 124(17):3375-84. PubMed ID: 9310332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signalling pathways.
    Morriss-Kay GM; Iseki S; Johnson D
    Novartis Found Symp; 2001; 232():102-16; discussion 116-21. PubMed ID: 11277075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craniosynostosis: from a clinical description to an understanding of bone formation of the skull.
    Lajeunie E; Catala M; Renier D
    Childs Nerv Syst; 1999 Nov; 15(11-12):676-80. PubMed ID: 10603009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3.
    Balek L; Gudernova I; Vesela I; Hampl M; Oralova V; Kunova Bosakova M; Varecha M; Nemec P; Hall T; Abbadessa G; Hatch N; Buchtova M; Krejci P
    Bone; 2017 Dec; 105():57-66. PubMed ID: 28826843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU; Spivak RM; Nah HD; Kirschner RE
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.